期刊文献+

临床药师参与1例心力衰竭、心肌梗死合并房颤患者的药物治疗

The Clinical Pharmacist Participated in the Drug Treatment of a Patient with Heart Failure,Myocardial Infarction and Atrial Fibrillation
下载PDF
导出
摘要 目的梳理复杂治疗方案后的抗栓方案,重整抗栓药物和疗程,纠正不合理用药,促进合理用药。方法临床药师介入1例心力衰竭、多次因心肌梗死植入多枚支架,合并房颤,行射频消融和左心耳封堵患者的药物治疗,重整抗栓药物方案,并全程监控治疗药物,就不合理用药提出警示。结果患者明显好转,住院及出院随访期间未发生不良事件。结论临床药师的参与有助于精细化管理患者的药物治疗方案,并及时纠正不合理用药,更好的为患者服务。 OBJECTIVE The antithrombotic plan after the complex treatment plan was sorted out,the antithrombotic drugs and the course of treatment were reformed to correct irrational drug use and promote rational drug use.METHODS Clinical pharmacists were involved in a case of heart failure,implantation of multiple stents for myocardial infarction for many times,combined with atrial fibrillation,performed radiofrequency ablation and left atrial appendage occlusion,reformed the antithrombotic drug regimen,and monitored the treatment drugs throughout the whole process to warn against unreasonable drug use.RESULTS The patient improved significantly,and no adverse events occurred during hospitalization and discharge follow-up.CONCLUSION The participation of clinical pharmacists is helpful to fine management of drug treatment plan for patients,timely correction of unreasonable drug use,and better service for patients.
作者 受国徽 苏会源 李波霞 SHOU Guo-hui;SU Hui-yuan;LI Bo-xia(Tianshui Hospital of Integrated Chinese and Western Medicine,Tianshui 741020,China;Linxia Hui Autonomous Prefecture People′s Hospital,Linxia 731100,China;The First Hospital of Lanzhou University,Lanzhou 730000,China)
出处 《海峡药学》 2024年第3期95-98,共4页 Strait Pharmaceutical Journal
基金 兰州大学第一医院院内基金ldyyyn2021-113。
关键词 心力衰竭 心肌梗死 PCI支架植入术 直接口服抗凝药物(DOAC Direct oral anticoagulants) 利伐沙班 新活素(注射用重组人脑利钠肽) 沙库巴曲缬沙坦 Heartfailure Myocardial infarction PCI stent implantation Direct oral anticoagulants(DOAC) Rivaroxaban Neoplasin(recombinant human brain natriuretic peptide for injection) Sacubitril Valsartan Sodium Tablets
  • 相关文献

参考文献6

二级参考文献118

  • 1托伐普坦临床研究协作组,张健,朱文玲.常规治疗基础上联用托伐普坦片治疗心原性水肿的有效性和安全性的多中心随机、双盲、安慰剂对照研究[J].中华心力衰竭和心肌病杂志(中英文),2017,1(1):15-21. 被引量:26
  • 2周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1397
  • 3胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量:162
  • 4张善春,刘兆昶.重组人脑利钠肽治疗心力衰竭[J].中国心血管杂志,2006,11(6):477-478. 被引量:33
  • 5Karl S, John C, Wlson S, et al. Guidelines for the diagnosis and treatment of chronic heart failure:executive summary[ J]. European Heart Journal,2005,26(6) :1115-1140.
  • 6Azzazy HM,Christenson RH. B-type natriuretic peptide:physiologic role and assay characteristics[J]. Heart Fail Rev ,2003, 8(4) :315-320.
  • 7Abraham WT, Lowes BD, Ferguson DA, et al. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain nalriuretic peptide in patients with hemodynarnically decompensated heart failure [ J ]. J Card Fail, 1998,4( 1 ) :37-44.
  • 8Michaels AD, Klein A, Madden JA, et al. Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake [ J ]. Circulation, 2003,107 ( 21 ) : 2697-2701.
  • 9Publication Committee for the VMAC Investigators ( Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycecin for ueatment of de, compensated congestive heart failure: a randomized controlled trial [ J ]. JAMA, 2002, 287(12) .. 1531-1540.
  • 10Marcus LS,Hart D,Packer M,et al. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebocontrolled,randomized crossover trial [ J]. Circulation, 1996, 94(12) :3184-3189.

共引文献1073

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部